Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Schweizerische Herzstiftung
Otsuka Pharmaceutical
Schweizerische Akademie der Medizinischen Wissenschaften
Daiichi Sankyo Europe
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial Fibrillation
Urs Fischer, Takenobu Kunieda, Yasuyuki Iguchi, Martina Goeldlin et al.
Journal
Journal of Stroke
Topics
Atrial Fibrillation Management and Outcomes
article
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial Fibrillation
Urs Fischer, Takenobu Kunieda, Yasuyuki Iguchi, Martina Goeldlin, Manju Krishnan, Kosuke Matsuzono, Sohei Yoshimura, Kanta Tanaka, Ḱazunori Toyoda, Yusuke Yakushiji, Vedamurthy Adhiyaman, Daniel Strbian, Alexander Salerno, Gerli Sibolt, Marjaana Tiainen, Masafumi Ihara, Masatoshi Koga, Hisanao Akiyama, Makoto Nakajima, Caterina Kulyk, Dimitri Hemelsoet, Peter Slade, Jesse Dawson, Takeshi Yoshimoto, David Julian Seiffge, Silja Räty, Jochen Vehoff, Mattia Branca, Shigeru Fujimoto, Thomas Horvath, Manabu Inoue
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of StrokeVol. 27(2)
Institutions
Jikei University School of Medicine (JP), University of Bern (CH), Johannes Kepler University of Linz (AT), Kansai Medical University (JP), Betsi Cadwaladr University Health Board (GB), Swansea Bay University Health Board (GB), University of Helsinki (FI), Jichi Medical University (JP), St. Marianna University School of Medicine (JP), Kantonsspital St. Gallen (CH), Helsinki University Hospital (FI), University Hospital of Bern (CH), Ghent University Hospital (BE), National Cerebral and Cardiovascular Center (JP), University of Glasgow (GB), Kumamoto University (JP), University of Lausanne (CH)
Funders
National Science Foundation, Pfizer, AstraZeneca, Biogen, Alexion Pharmaceuticals, CSL Behring, Stryker, Schweizerischen Neurologischen Gesellschaft, Kowa Company, Japan Blood Products Organization, Boehringer Ingelheim Japan, Stroke Association, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Schweizerische Herzstiftung, Otsuka Pharmaceutical, Schweizerische Akademie der Medizinischen Wissenschaften, Daiichi Sankyo Europe